Global Human Microbiome Market Size, Share & Industry Trends Analysis Report By Product, By Disease Type, By Technology, By Application, By Type, By Regional Outlook and Forecast, 2022 - 2028

The Global Human Microbiome Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 32.2% CAGR during the forecast period.

The human microbiome is made up of all microbes found on or in human tissues and biofluids, as well as the anatomical places where they live, such as the skin, seminal fluid, mammary glands, uterus, ovarian follicles, saliva, oral mucosa, biliary tract, conjunctiva, and gastrointestinal tract. Bacteria, archaea, fungus, protists, and viruses are all examples of the human microbiota. Despite the fact that micro-animals can survive on humans, they are usually excluded from this description. The term human microbiome is sometimes used in genomics to refer to the aggregate genomes of resident bacteria. Human metagenome, on the other hand, has the same connotation.

Bacteria, viruses, archaea, and eukaryotes live both inside and outside of human bodies, making up the human microbiome. These organisms have an impact on human physiology in both health and disease, enhancing or inhibiting metabolic and immunological systems. Microorganisms colonize diverse areas on and inside the human body, adapting to the unique characteristics of each niche. The gastrointestinal tract is dominated by facultative anaerobes, whereas the nasal cavity, respiratory tract, and skin surface are dominated by strict aerobes. Because of the biological connection of the organisms with the immune system throughout time, the indigenous organisms inside the human body are well adapted to the immune system. Human health and disease etiology are both influenced by changes in the gut microbial flora. These changes are caused by lifestyle choices and the prevalence of an illness. Dysbiosis makes the host more vulnerable to infection, the type of which varies on the anatomical place. The precise metabolic activities and functions of these microorganisms within each bodily location are compensated by the inherent diversity of the human microbiota. As a result, it's critical to comprehend the human microbiome's microbial composition and behaviors as they relate to health and disease.

COVID-19 Impact Analysis

The COVID-19 pandemic significantly impacted various businesses all over the world. Several developed, developing, and under-developed economies were also demolished due to the advent of the COVID-19 pandemic. In addition, to regulate the rapid diffusion of the infection, governments all over the world enforced stringent lockdown in their countries. The imposition of lockdown across countries resulted in a temporary closure of various companies, businesses, and manufacturing units of several goods and services. Moreover, as a result of government-imposed travel restrictions, the global supply chain was also disrupted. Further, the healthcare sector of all the countries across the world was devastated, which placed a massive burden on researchers and scientists.

Market Growth Factors

Rising focus on the development of therapeutics

The efficiency of medicinal drugs is significantly influenced by the microbiome of the human gut. Several studies have demonstrated that the appropriate balance of microorganisms in the human body can help treat a variety of ailments over time. This link between bacteria and specific diseases may open up new possibilities for drug developers (or vaccine manufacturers). Because microbes are rich in enzymes, they can be exploited in a variety of therapeutic applications, including the search for new medicines. Microbiome therapy has grown in popularity in recent years. The National Institutes of Health (NIH) spent USD 215 million on the Human Microbiome Project (HMP) along with USD 728 million on extramural human microbiome research initiatives outside of the HMP over a ten-year period (fiscal years 2007–2016).

Application in cancer treatment

The gut microbiota has been linked to cancer and has been found to boost the efficacy of anticancer drugs. Resistance to chemo medicines or immune checkpoint inhibitors is linked to the altered gut microbiota, whereas supplementation with other bacterial species restores anticancer treatment responses. Altering the gut microbiota can improve the efficacy of anticancer medicines. Regardless of the important findings from preclinical models and clinical data from cancer patients, a better understanding of the microbiota's interactions with cancer therapy can help researchers develop new cancer prevention strategies, stratify patients for more effective treatment, and reduce treatment complications.

Marketing Restraining Factor:

Stringent government regulations

Probiotics have not been approved by the FDA as a live biotherapeutic product, which is a biological outcome instead of a vaccine that includes live organisms employed to prevent or cure a disease or condition in humans. However, there are FDA-regulated foods containing probiotics that are legally available, including dietary supplements, and these items cannot be sold to cure, treat, mitigate, or prevent any diseases. Probiotic supplements are heavily promoted in both retail stores and on the internet. Whereas the FDA has not yet approved any probiotics for therapeutic use, some are currently undergoing clinical trials and may soon be sold as biologics or other medications or would be exempted from sellable biological products. The existing FDA regulatory standards for probiotics are not tailored.

Product Outlook

Based on Product, the market is segmented into Drugs, Diagnostic Tests, Probiotics, Prebiotics, and Others. In 2021, the drugs segment acquired the largest revenue share of the human microbiome market. The growing number of human microbiome-based therapeutic products in clinical trials, as well as increased funding to develop microbiome-based medications, can be linked to the growth of this segment. Moreover, the increasing efficiency of human microbiome-based drugs is another factor that is propelling the growth of the segment.

Disease Type Outlook

Based on Disease Type, the market is segmented into Infectious Diseases, Endocrine & Metabolic Disorders, Gastrointestinal Diseases, Cancer, and Others. In 2021, the gastrointestinal diseases segment recorded a significant reve3nue share of the human microbiome market. The increasing growth of this segment is attributed to the rising prevalence of gastrointestinal diseases. The phrase gastrointestinal disorders refer to any ailment or disease that affects the gastrointestinal tract. The gastrointestinal tract (also known as the GI tract) is a collection of hollow organs that run from the mouth to the stomach.

Technology Outlook

Based on Technology, the market is segmented into Genomics, Proteomics and Metabolomics. In 2021, the genomics segment procured the highest revenue share of the human microbiome market. A crucial driver for the genomics market is the growing number of initiatives financed by corporate and government entities. With the increasing number of government support initiatives, the growth of this segment is estimated to significantly surge during the forecast period. WGS (whole genome sequencing) is a method for examining complete genomes. Identifying inherited illnesses, defining the mutations that cause cancer progression, as well as tracking disease outbreaks have all benefited from genomic information.

Application Outlook

Based on Application, the market is segmented into Therapeutics and Diagnostics. In 2021, the diagnosis segment registered a substantial revenue share of the human microbiome market. The gut microbiota has the potential to be used as a diagnostic biomarker for HCC precancerous conditions, which is propelling the growth of this segment. The gut microbiome also serves as a diagnostic indicator for HCC. The oral microbiota has the potential to be used as a diagnostic biomarker for HCC precancerous conditions.

Type Outlook

Based on Type, the market is segmented into Microbiome Consortia Transplantation (FMT), Peptide, Live Biotherapeutic Product and Others. In 2021, the microbiome consortia transplantation (FMT) segment recorded the largest revenue share of the human microbiome market. The growth of this segment is attributed to the fact that recurrent Clostridium difficile infection can be successfully treated with FMT. The introduction of a solution of fecal material from a donor into the intestinal tract of a receiver in order to directly affect the recipient's gut microbial composition and bestow a health benefit is known as fecal microbiota transplantation (FMT).

Human Microbiome Market Report Coverage

Report Attribute	Details
Market size value in 2021	USD 164.4 Million
Market size forecast in 2028	USD 1.1 Billion
Base Year	2021
Historical Period	2018 to 2020
Forecast Period	2022 to 2028
Revenue Growth Rate	CAGR of 32.2% from 2022 to 2028
Number of Pages	296
Number of Tables	569
Report coverage	Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Companies Strategic Developments, Company Profiling
Segments covered	Product, Disease Type, Technology, Application, Type, Region
Country scope	US, Canada, Mexico, Germany, UK, France, Russia, Spain, Italy, China, Japan, India, South Korea, Singapore, Malaysia, Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria
Growth Drivers	Rising focus on the development of therapeutics Application in cancer treatment
Restraints	Stringent government regulations

Regional Outlook

Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa. In 20212, North America accounted for the largest revenue share of the human microbiome market. The market in North America is being driven by factors such as the rising prevalence of lifestyle illnesses, rising awareness of preventative healthcare, the availability of financing for microbiome research, and the growing number of microbiome research and clinical activities.

Free Valuable Insights: Global Human Microbiome Market size to reach USD 1.1 Billion by 2028

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Seres Therapeutics, Inc., 4D pharma plc, OptiBiotix Health Plc, Synlogic, Inc., Second Genome, Inc., Vedanta Biosciences, Inc., Finch Therapeutics Group, Inc., Ferring Holdings SA, and Enterome.

Scope of the Study

Market Segments Covered in the Report:

By Product

• Drugs
• Diagnostic Tests
• Probiotics
• Prebiotics, and
• Others

By Disease Type

• Infectious Diseases
• Endocrine & Metabolic Disorders
• Gastrointestinal Diseases
• Cancer, and
• Others

By Technology

• Genomics
• Proteomics
• Metabolomics

By Application

• Therapeutics
• Diagnostics

By Type

• Microbiome Consortia Transplantation (FMT)
• Peptide
• Live Biotherapeutic Product
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

• Seres Therapeutics, Inc.
• 4D pharma plc
• OptiBiotix Health Plc
• Synlogic, Inc.
• Second Genome, Inc.
• Vedanta Biosciences, Inc.
• Finch Therapeutics Group, Inc.
• Ferring Holdings SA
• Enterome

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Human Microbiome Market, by Product
1.4.2 Global Human Microbiome Market, by Disease Type
1.4.3 Global Human Microbiome Market, by Technology
1.4.4 Global Human Microbiome Market, by Application
1.4.5 Global Human Microbiome Market, by Type
1.4.6 Global Human Microbiome Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Human Microbiome Market by Product
3.1 Global Drugs Market by Region
3.2 Global Diagnostic Tests Market by Region
3.3 Global Probiotics Market by Region
3.4 Global Prebiotics Market by Region
3.5 Global Others Market by Region

Chapter 4. Global Human Microbiome Market by Disease Type
4.1 Global Infectious Diseases Market by Region
4.2 Global Endocrine & Metabolic Disorders Market by Region
4.3 Global Gastrointestinal Diseases Market by Region
4.4 Global Cancer Market by Region
4.5 Global Others Market by Region

Chapter 5. Global Human Microbiome Market by Technology
5.1 Global Genomics Market by Region
5.2 Global Proteomics Market by Region
5.3 Global Metabolomics Market by Region

Chapter 6. Global Human Microbiome Market by Application
6.1 Global Therapeutics Market by Region
6.2 Global Diagnostics Market by Region

Chapter 7. Global Human Microbiome Market by Type
7.1 Global Microbiome Consortia Transplantation (FMT) Market by Region
7.2 Global Peptide Market by Region
7.3 Global Live Biotherapeutic Product Market by Region
7.4 Global Others Market by Region

Chapter 8. Global Human Microbiome Market by Region
8.1 North America Human Microbiome Market
8.1.1 North America Human Microbiome Market by Product
8.1.1.1 North America Drugs Market by Country
8.1.1.2 North America Diagnostic Tests Market by Country
8.1.1.3 North America Probiotics Market by Country
8.1.1.4 North America Prebiotics Market by Country
8.1.1.5 North America Others Market by Country
8.1.2 North America Human Microbiome Market by Disease Type
8.1.2.1 North America Infectious Diseases Market by Country
8.1.2.2 North America Endocrine & Metabolic Disorders Market by Country
8.1.2.3 North America Gastrointestinal Diseases Market by Country
8.1.2.4 North America Cancer Market by Country
8.1.2.5 North America Others Market by Country
8.1.3 North America Human Microbiome Market by Technology
8.1.3.1 North America Genomics Market by Country
8.1.3.2 North America Proteomics Market by Country
8.1.3.3 North America Metabolomics Market by Country
8.1.4 North America Human Microbiome Market by Application
8.1.4.1 North America Therapeutics Market by Country
8.1.4.2 North America Diagnostics Market by Country
8.1.5 North America Human Microbiome Market by Type
8.1.5.1 North America Microbiome Consortia Transplantation (FMT) Market by Country
8.1.5.2 North America Peptide Market by Country
8.1.5.3 North America Live Biotherapeutic Product Market by Country
8.1.5.4 North America Others Market by Country
8.1.6 North America Human Microbiome Market by Country
8.1.6.1 US Human Microbiome Market
8.1.6.1.1 US Human Microbiome Market by Product
8.1.6.1.2 US Human Microbiome Market by Disease Type
8.1.6.1.3 US Human Microbiome Market by Technology
8.1.6.1.4 US Human Microbiome Market by Application
8.1.6.1.5 US Human Microbiome Market by Type
8.1.6.2 Canada Human Microbiome Market
8.1.6.2.1 Canada Human Microbiome Market by Product
8.1.6.2.2 Canada Human Microbiome Market by Disease Type
8.1.6.2.3 Canada Human Microbiome Market by Technology
8.1.6.2.4 Canada Human Microbiome Market by Application
8.1.6.2.5 Canada Human Microbiome Market by Type
8.1.6.3 Mexico Human Microbiome Market
8.1.6.3.1 Mexico Human Microbiome Market by Product
8.1.6.3.2 Mexico Human Microbiome Market by Disease Type
8.1.6.3.3 Mexico Human Microbiome Market by Technology
8.1.6.3.4 Mexico Human Microbiome Market by Application
8.1.6.3.5 Mexico Human Microbiome Market by Type
8.1.6.4 Rest of North America Human Microbiome Market
8.1.6.4.1 Rest of North America Human Microbiome Market by Product
8.1.6.4.2 Rest of North America Human Microbiome Market by Disease Type
8.1.6.4.3 Rest of North America Human Microbiome Market by Technology
8.1.6.4.4 Rest of North America Human Microbiome Market by Application
8.1.6.4.5 Rest of North America Human Microbiome Market by Type
8.2 Europe Human Microbiome Market
8.2.1 Europe Human Microbiome Market by Product
8.2.1.1 Europe Drugs Market by Country
8.2.1.2 Europe Diagnostic Tests Market by Country
8.2.1.3 Europe Probiotics Market by Country
8.2.1.4 Europe Prebiotics Market by Country
8.2.1.5 Europe Others Market by Country
8.2.2 Europe Human Microbiome Market by Disease Type
8.2.2.1 Europe Infectious Diseases Market by Country
8.2.2.2 Europe Endocrine & Metabolic Disorders Market by Country
8.2.2.3 Europe Gastrointestinal Diseases Market by Country
8.2.2.4 Europe Cancer Market by Country
8.2.2.5 Europe Others Market by Country
8.2.3 Europe Human Microbiome Market by Technology
8.2.3.1 Europe Genomics Market by Country
8.2.3.2 Europe Proteomics Market by Country
8.2.3.3 Europe Metabolomics Market by Country
8.2.4 Europe Human Microbiome Market by Application
8.2.4.1 Europe Therapeutics Market by Country
8.2.4.2 Europe Diagnostics Market by Country
8.2.5 Europe Human Microbiome Market by Type
8.2.5.1 Europe Microbiome Consortia Transplantation (FMT) Market by Country
8.2.5.2 Europe Peptide Market by Country
8.2.5.3 Europe Live Biotherapeutic Product Market by Country
8.2.5.4 Europe Others Market by Country
8.2.6 Europe Human Microbiome Market by Country
8.2.6.1 Germany Human Microbiome Market
8.2.6.1.1 Germany Human Microbiome Market by Product
8.2.6.1.2 Germany Human Microbiome Market by Disease Type
8.2.6.1.3 Germany Human Microbiome Market by Technology
8.2.6.1.4 Germany Human Microbiome Market by Application
8.2.6.1.5 Germany Human Microbiome Market by Type
8.2.6.2 UK Human Microbiome Market
8.2.6.2.1 UK Human Microbiome Market by Product
8.2.6.2.2 UK Human Microbiome Market by Disease Type
8.2.6.2.3 UK Human Microbiome Market by Technology
8.2.6.2.4 UK Human Microbiome Market by Application
8.2.6.2.5 UK Human Microbiome Market by Type
8.2.6.3 France Human Microbiome Market
8.2.6.3.1 France Human Microbiome Market by Product
8.2.6.3.2 France Human Microbiome Market by Disease Type
8.2.6.3.3 France Human Microbiome Market by Technology
8.2.6.3.4 France Human Microbiome Market by Application
8.2.6.3.5 France Human Microbiome Market by Type
8.2.6.4 Russia Human Microbiome Market
8.2.6.4.1 Russia Human Microbiome Market by Product
8.2.6.4.2 Russia Human Microbiome Market by Disease Type
8.2.6.4.3 Russia Human Microbiome Market by Technology
8.2.6.4.4 Russia Human Microbiome Market by Application
8.2.6.4.5 Russia Human Microbiome Market by Type
8.2.6.5 Spain Human Microbiome Market
8.2.6.5.1 Spain Human Microbiome Market by Product
8.2.6.5.2 Spain Human Microbiome Market by Disease Type
8.2.6.5.3 Spain Human Microbiome Market by Technology
8.2.6.5.4 Spain Human Microbiome Market by Application
8.2.6.5.5 Spain Human Microbiome Market by Type
8.2.6.6 Italy Human Microbiome Market
8.2.6.6.1 Italy Human Microbiome Market by Product
8.2.6.6.2 Italy Human Microbiome Market by Disease Type
8.2.6.6.3 Italy Human Microbiome Market by Technology
8.2.6.6.4 Italy Human Microbiome Market by Application
8.2.6.6.5 Italy Human Microbiome Market by Type
8.2.6.7 Rest of Europe Human Microbiome Market
8.2.6.7.1 Rest of Europe Human Microbiome Market by Product
8.2.6.7.2 Rest of Europe Human Microbiome Market by Disease Type
8.2.6.7.3 Rest of Europe Human Microbiome Market by Technology
8.2.6.7.4 Rest of Europe Human Microbiome Market by Application
8.2.6.7.5 Rest of Europe Human Microbiome Market by Type
8.3 Asia Pacific Human Microbiome Market
8.3.1 Asia Pacific Human Microbiome Market by Product
8.3.1.1 Asia Pacific Drugs Market by Country
8.3.1.2 Asia Pacific Diagnostic Tests Market by Country
8.3.1.3 Asia Pacific Probiotics Market by Country
8.3.1.4 Asia Pacific Prebiotics Market by Country
8.3.1.5 Asia Pacific Others Market by Country
8.3.2 Asia Pacific Human Microbiome Market by Disease Type
8.3.2.1 Asia Pacific Infectious Diseases Market by Country
8.3.2.2 Asia Pacific Endocrine & Metabolic Disorders Market by Country
8.3.2.3 Asia Pacific Gastrointestinal Diseases Market by Country
8.3.2.4 Asia Pacific Cancer Market by Country
8.3.2.5 Asia Pacific Others Market by Country
8.3.3 Asia Pacific Human Microbiome Market by Technology
8.3.3.1 Asia Pacific Genomics Market by Country
8.3.3.2 Asia Pacific Proteomics Market by Country
8.3.3.3 Asia Pacific Metabolomics Market by Country
8.3.4 Asia Pacific Human Microbiome Market by Application
8.3.4.1 Asia Pacific Therapeutics Market by Country
8.3.4.2 Asia Pacific Diagnostics Market by Country
8.3.5 Asia Pacific Human Microbiome Market by Type
8.3.5.1 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country
8.3.5.2 Asia Pacific Peptide Market by Country
8.3.5.3 Asia Pacific Live Biotherapeutic Product Market by Country
8.3.5.4 Asia Pacific Others Market by Country
8.3.6 Asia Pacific Human Microbiome Market by Country
8.3.6.1 China Human Microbiome Market
8.3.6.1.1 China Human Microbiome Market by Product
8.3.6.1.2 China Human Microbiome Market by Disease Type
8.3.6.1.3 China Human Microbiome Market by Technology
8.3.6.1.4 China Human Microbiome Market by Application
8.3.6.1.5 China Human Microbiome Market by Type
8.3.6.2 Japan Human Microbiome Market
8.3.6.2.1 Japan Human Microbiome Market by Product
8.3.6.2.2 Japan Human Microbiome Market by Disease Type
8.3.6.2.3 Japan Human Microbiome Market by Technology
8.3.6.2.4 Japan Human Microbiome Market by Application
8.3.6.2.5 Japan Human Microbiome Market by Type
8.3.6.3 India Human Microbiome Market
8.3.6.3.1 India Human Microbiome Market by Product
8.3.6.3.2 India Human Microbiome Market by Disease Type
8.3.6.3.3 India Human Microbiome Market by Technology
8.3.6.3.4 India Human Microbiome Market by Application
8.3.6.3.5 India Human Microbiome Market by Type
8.3.6.4 South Korea Human Microbiome Market
8.3.6.4.1 South Korea Human Microbiome Market by Product
8.3.6.4.2 South Korea Human Microbiome Market by Disease Type
8.3.6.4.3 South Korea Human Microbiome Market by Technology
8.3.6.4.4 South Korea Human Microbiome Market by Application
8.3.6.4.5 South Korea Human Microbiome Market by Type
8.3.6.5 Singapore Human Microbiome Market
8.3.6.5.1 Singapore Human Microbiome Market by Product
8.3.6.5.2 Singapore Human Microbiome Market by Disease Type
8.3.6.5.3 Singapore Human Microbiome Market by Technology
8.3.6.5.4 Singapore Human Microbiome Market by Application
8.3.6.5.5 Singapore Human Microbiome Market by Type
8.3.6.6 Malaysia Human Microbiome Market
8.3.6.6.1 Malaysia Human Microbiome Market by Product
8.3.6.6.2 Malaysia Human Microbiome Market by Disease Type
8.3.6.6.3 Malaysia Human Microbiome Market by Technology
8.3.6.6.4 Malaysia Human Microbiome Market by Application
8.3.6.6.5 Malaysia Human Microbiome Market by Type
8.3.6.7 Rest of Asia Pacific Human Microbiome Market
8.3.6.7.1 Rest of Asia Pacific Human Microbiome Market by Product
8.3.6.7.2 Rest of Asia Pacific Human Microbiome Market by Disease Type
8.3.6.7.3 Rest of Asia Pacific Human Microbiome Market by Technology
8.3.6.7.4 Rest of Asia Pacific Human Microbiome Market by Application
8.3.6.7.5 Rest of Asia Pacific Human Microbiome Market by Type
8.4 LAMEA Human Microbiome Market
8.4.1 LAMEA Human Microbiome Market by Product
8.4.1.1 LAMEA Drugs Market by Country
8.4.1.2 LAMEA Diagnostic Tests Market by Country
8.4.1.3 LAMEA Probiotics Market by Country
8.4.1.4 LAMEA Prebiotics Market by Country
8.4.1.5 LAMEA Others Market by Country
8.4.2 LAMEA Human Microbiome Market by Disease Type
8.4.2.1 LAMEA Infectious Diseases Market by Country
8.4.2.2 LAMEA Endocrine & Metabolic Disorders Market by Country
8.4.2.3 LAMEA Gastrointestinal Diseases Market by Country
8.4.2.4 LAMEA Cancer Market by Country
8.4.2.5 LAMEA Others Market by Country
8.4.3 LAMEA Human Microbiome Market by Technology
8.4.3.1 LAMEA Genomics Market by Country
8.4.3.2 LAMEA Proteomics Market by Country
8.4.3.3 LAMEA Metabolomics Market by Country
8.4.4 LAMEA Human Microbiome Market by Application
8.4.4.1 LAMEA Therapeutics Market by Country
8.4.4.2 LAMEA Diagnostics Market by Country
8.4.5 LAMEA Human Microbiome Market by Type
8.4.5.1 LAMEA Microbiome Consortia Transplantation (FMT) Market by Country
8.4.5.2 LAMEA Peptide Market by Country
8.4.5.3 LAMEA Live Biotherapeutic Product Market by Country
8.4.5.4 LAMEA Others Market by Country
8.4.6 LAMEA Human Microbiome Market by Country
8.4.6.1 Brazil Human Microbiome Market
8.4.6.1.1 Brazil Human Microbiome Market by Product
8.4.6.1.2 Brazil Human Microbiome Market by Disease Type
8.4.6.1.3 Brazil Human Microbiome Market by Technology
8.4.6.1.4 Brazil Human Microbiome Market by Application
8.4.6.1.5 Brazil Human Microbiome Market by Type
8.4.6.2 Argentina Human Microbiome Market
8.4.6.2.1 Argentina Human Microbiome Market by Product
8.4.6.2.2 Argentina Human Microbiome Market by Disease Type
8.4.6.2.3 Argentina Human Microbiome Market by Technology
8.4.6.2.4 Argentina Human Microbiome Market by Application
8.4.6.2.5 Argentina Human Microbiome Market by Type
8.4.6.3 UAE Human Microbiome Market
8.4.6.3.1 UAE Human Microbiome Market by Product
8.4.6.3.2 UAE Human Microbiome Market by Disease Type
8.4.6.3.3 UAE Human Microbiome Market by Technology
8.4.6.3.4 UAE Human Microbiome Market by Application
8.4.6.3.5 UAE Human Microbiome Market by Type
8.4.6.4 Saudi Arabia Human Microbiome Market
8.4.6.4.1 Saudi Arabia Human Microbiome Market by Product
8.4.6.4.2 Saudi Arabia Human Microbiome Market by Disease Type
8.4.6.4.3 Saudi Arabia Human Microbiome Market by Technology
8.4.6.4.4 Saudi Arabia Human Microbiome Market by Application
8.4.6.4.5 Saudi Arabia Human Microbiome Market by Type
8.4.6.5 South Africa Human Microbiome Market
8.4.6.5.1 South Africa Human Microbiome Market by Product
8.4.6.5.2 South Africa Human Microbiome Market by Disease Type
8.4.6.5.3 South Africa Human Microbiome Market by Technology
8.4.6.5.4 South Africa Human Microbiome Market by Application
8.4.6.5.5 South Africa Human Microbiome Market by Type
8.4.6.6 Nigeria Human Microbiome Market
8.4.6.6.1 Nigeria Human Microbiome Market by Product
8.4.6.6.2 Nigeria Human Microbiome Market by Disease Type
8.4.6.6.3 Nigeria Human Microbiome Market by Technology
8.4.6.6.4 Nigeria Human Microbiome Market by Application
8.4.6.6.5 Nigeria Human Microbiome Market by Type
8.4.6.7 Rest of LAMEA Human Microbiome Market
8.4.6.7.1 Rest of LAMEA Human Microbiome Market by Product
8.4.6.7.2 Rest of LAMEA Human Microbiome Market by Disease Type
8.4.6.7.3 Rest of LAMEA Human Microbiome Market by Technology
8.4.6.7.4 Rest of LAMEA Human Microbiome Market by Application
8.4.6.7.5 Rest of LAMEA Human Microbiome Market by Type

Chapter 9. Company Profiles
9.1 Ferring Holdings SA
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Regional Analysis
9.1.4 Research and Development Expense
9.1.5 Recent Strategies and Developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.2 Enterome
9.2.1 Company Overview
9.2.2 Recent Strategies and Developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.3 Seres Therapeutics, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Research & Development Expense
9.3.4 Recent Strategies and Developments:
9.3.4.1 Partnerships, Collaborations, and Agreements:
9.4 4D Pharma Plc
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Research & Development Expense
9.4.4 Recent Strategies and Developments:
9.4.4.1 Partnerships, Collaborations, and Agreements:
9.5 OptiBiotix Health Plc
9.5.1 Company Overview
9.6 Synlogic, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Research & Development Expense
9.7 Second Genome, Inc.
9.7.1 Company Overview
9.8 Vedanta Biosciences, Inc.
9.8.1 Company Overview
9.9 Finch Therapeutics Group, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Research & Development Expense

TABLE 1 Global Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 2 Global Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 3 Global Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 4 Global Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 5 Global Drugs Market by Region, 2018 - 2021, USD Thousands
TABLE 6 Global Drugs Market by Region, 2022 - 2028, USD Thousands
TABLE 7 Global Diagnostic Tests Market by Region, 2018 - 2021, USD Thousands
TABLE 8 Global Diagnostic Tests Market by Region, 2022 - 2028, USD Thousands
TABLE 9 Global Probiotics Market by Region, 2018 - 2021, USD Thousands
TABLE 10 Global Probiotics Market by Region, 2022 - 2028, USD Thousands
TABLE 11 Global Prebiotics Market by Region, 2018 - 2021, USD Thousands
TABLE 12 Global Prebiotics Market by Region, 2022 - 2028, USD Thousands
TABLE 13 Global Others Market by Region, 2018 - 2021, USD Thousands
TABLE 14 Global Others Market by Region, 2022 - 2028, USD Thousands
TABLE 15 Global Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 16 Global Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 17 Global Infectious Diseases Market by Region, 2018 - 2021, USD Thousands
TABLE 18 Global Infectious Diseases Market by Region, 2022 - 2028, USD Thousands
TABLE 19 Global Endocrine & Metabolic Disorders Market by Region, 2018 - 2021, USD Thousands
TABLE 20 Global Endocrine & Metabolic Disorders Market by Region, 2022 - 2028, USD Thousands
TABLE 21 Global Gastrointestinal Diseases Market by Region, 2018 - 2021, USD Thousands
TABLE 22 Global Gastrointestinal Diseases Market by Region, 2022 - 2028, USD Thousands
TABLE 23 Global Cancer Market by Region, 2018 - 2021, USD Thousands
TABLE 24 Global Cancer Market by Region, 2022 - 2028, USD Thousands
TABLE 25 Global Others Market by Region, 2018 - 2021, USD Thousands
TABLE 26 Global Others Market by Region, 2022 - 2028, USD Thousands
TABLE 27 Global Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 28 Global Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 29 Global Genomics Market by Region, 2018 - 2021, USD Thousands
TABLE 30 Global Genomics Market by Region, 2022 - 2028, USD Thousands
TABLE 31 Global Proteomics Market by Region, 2018 - 2021, USD Thousands
TABLE 32 Global Proteomics Market by Region, 2022 - 2028, USD Thousands
TABLE 33 Global Metabolomics Market by Region, 2018 - 2021, USD Thousands
TABLE 34 Global Metabolomics Market by Region, 2022 - 2028, USD Thousands
TABLE 35 Global Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 36 Global Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 37 Global Therapeutics Market by Region, 2018 - 2021, USD Thousands
TABLE 38 Global Therapeutics Market by Region, 2022 - 2028, USD Thousands
TABLE 39 Global Diagnostics Market by Region, 2018 - 2021, USD Thousands
TABLE 40 Global Diagnostics Market by Region, 2022 - 2028, USD Thousands
TABLE 41 Global Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 42 Global Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 43 Global Microbiome Consortia Transplantation (FMT) Market by Region, 2018 - 2021, USD Thousands
TABLE 44 Global Microbiome Consortia Transplantation (FMT) Market by Region, 2022 - 2028, USD Thousands
TABLE 45 Global Peptide Market by Region, 2018 - 2021, USD Thousands
TABLE 46 Global Peptide Market by Region, 2022 - 2028, USD Thousands
TABLE 47 Global Live Biotherapeutic Product Market by Region, 2018 - 2021, USD Thousands
TABLE 48 Global Live Biotherapeutic Product Market by Region, 2022 - 2028, USD Thousands
TABLE 49 Global Others Market by Region, 2018 - 2021, USD Thousands
TABLE 50 Global Others Market by Region, 2022 - 2028, USD Thousands
TABLE 51 Global Human Microbiome Market by Region, 2018 - 2021, USD Thousands
TABLE 52 Global Human Microbiome Market by Region, 2022 - 2028, USD Thousands
TABLE 53 North America Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 54 North America Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 55 North America Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 56 North America Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 57 North America Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 58 North America Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 59 North America Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 60 North America Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 61 North America Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 62 North America Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 63 North America Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 64 North America Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 65 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 66 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 67 North America Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 68 North America Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 69 North America Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 70 North America Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 71 North America Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 72 North America Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 73 North America Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 74 North America Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 75 North America Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 76 North America Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 77 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 78 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 79 North America Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 80 North America Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 81 North America Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 82 North America Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 83 North America Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 84 North America Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 85 North America Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 86 North America Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 87 North America Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 88 North America Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 89 North America Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 90 North America Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 91 North America Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 92 North America Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 93 North America Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 94 North America Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 95 North America Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 96 North America Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 97 North America Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 98 North America Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 99 North America Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 100 North America Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 101 North America Others Market by Country, 2018 - 2021, USD Thousands
TABLE 102 North America Others Market by Country, 2022 - 2028, USD Thousands
TABLE 103 North America Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 104 North America Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 105 US Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 106 US Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 107 US Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 108 US Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 109 US Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 110 US Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 111 US Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 112 US Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 113 US Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 114 US Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 115 US Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 116 US Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 117 Canada Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 118 Canada Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 119 Canada Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 120 Canada Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 121 Canada Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 122 Canada Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 123 Canada Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 124 Canada Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 125 Canada Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 126 Canada Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 127 Canada Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 128 Canada Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 129 Mexico Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 130 Mexico Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 131 Mexico Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 132 Mexico Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 133 Mexico Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 134 Mexico Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 135 Mexico Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 136 Mexico Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 137 Mexico Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 138 Mexico Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 139 Mexico Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 140 Mexico Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 141 Rest of North America Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 142 Rest of North America Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 143 Rest of North America Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 144 Rest of North America Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 145 Rest of North America Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 146 Rest of North America Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 147 Rest of North America Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 148 Rest of North America Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 149 Rest of North America Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 150 Rest of North America Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 151 Rest of North America Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 152 Rest of North America Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 153 Europe Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 154 Europe Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 155 Europe Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 156 Europe Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 157 Europe Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 158 Europe Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 159 Europe Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 160 Europe Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 161 Europe Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 162 Europe Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 163 Europe Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 164 Europe Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 165 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 166 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 167 Europe Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 168 Europe Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 169 Europe Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 170 Europe Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 171 Europe Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 172 Europe Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 173 Europe Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 174 Europe Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 175 Europe Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 176 Europe Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 177 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 178 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 179 Europe Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 180 Europe Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 181 Europe Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 182 Europe Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 183 Europe Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 184 Europe Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 185 Europe Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 186 Europe Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 187 Europe Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 188 Europe Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 189 Europe Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 190 Europe Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 191 Europe Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 192 Europe Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 193 Europe Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 194 Europe Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 195 Europe Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 196 Europe Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 197 Europe Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 198 Europe Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 199 Europe Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 200 Europe Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 201 Europe Others Market by Country, 2018 - 2021, USD Thousands
TABLE 202 Europe Others Market by Country, 2022 - 2028, USD Thousands
TABLE 203 Europe Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 204 Europe Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 205 Germany Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 206 Germany Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 207 Germany Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 208 Germany Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 209 Germany Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 210 Germany Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 211 Germany Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 212 Germany Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 213 Germany Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 214 Germany Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 215 Germany Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 216 Germany Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 217 UK Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 218 UK Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 219 UK Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 220 UK Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 221 UK Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 222 UK Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 223 UK Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 224 UK Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 225 UK Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 226 UK Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 227 UK Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 228 UK Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 229 France Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 230 France Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 231 France Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 232 France Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 233 France Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 234 France Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 235 France Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 236 France Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 237 France Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 238 France Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 239 France Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 240 France Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 241 Russia Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 242 Russia Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 243 Russia Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 244 Russia Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 245 Russia Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 246 Russia Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 247 Russia Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 248 Russia Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 249 Russia Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 250 Russia Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 251 Russia Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 252 Russia Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 253 Spain Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 254 Spain Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 255 Spain Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 256 Spain Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 257 Spain Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 258 Spain Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 259 Spain Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 260 Spain Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 261 Spain Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 262 Spain Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 263 Spain Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 264 Spain Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 265 Italy Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 266 Italy Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 267 Italy Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 268 Italy Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 269 Italy Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 270 Italy Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 271 Italy Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 272 Italy Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 273 Italy Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 274 Italy Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 275 Italy Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 276 Italy Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 277 Rest of Europe Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 278 Rest of Europe Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 279 Rest of Europe Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 280 Rest of Europe Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 281 Rest of Europe Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 282 Rest of Europe Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 283 Rest of Europe Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 284 Rest of Europe Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 285 Rest of Europe Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 286 Rest of Europe Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 287 Rest of Europe Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 288 Rest of Europe Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 289 Asia Pacific Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 290 Asia Pacific Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 291 Asia Pacific Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 292 Asia Pacific Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 293 Asia Pacific Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 294 Asia Pacific Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 295 Asia Pacific Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 296 Asia Pacific Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 297 Asia Pacific Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 298 Asia Pacific Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 299 Asia Pacific Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 300 Asia Pacific Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 301 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 302 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 303 Asia Pacific Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 304 Asia Pacific Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 305 Asia Pacific Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 306 Asia Pacific Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 307 Asia Pacific Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 308 Asia Pacific Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 309 Asia Pacific Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 310 Asia Pacific Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 311 Asia Pacific Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 312 Asia Pacific Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 313 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 314 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 315 Asia Pacific Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 316 Asia Pacific Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 317 Asia Pacific Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 318 Asia Pacific Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 319 Asia Pacific Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 320 Asia Pacific Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 321 Asia Pacific Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 322 Asia Pacific Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 323 Asia Pacific Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 324 Asia Pacific Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 325 Asia Pacific Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 326 Asia Pacific Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 327 Asia Pacific Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 328 Asia Pacific Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 329 Asia Pacific Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 330 Asia Pacific Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 331 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 332 Asia Pacific Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 333 Asia Pacific Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 334 Asia Pacific Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 335 Asia Pacific Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 336 Asia Pacific Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 337 Asia Pacific Others Market by Country, 2018 - 2021, USD Thousands
TABLE 338 Asia Pacific Others Market by Country, 2022 - 2028, USD Thousands
TABLE 339 Asia Pacific Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 340 Asia Pacific Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 341 China Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 342 China Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 343 China Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 344 China Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 345 China Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 346 China Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 347 China Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 348 China Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 349 China Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 350 China Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 351 China Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 352 China Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 353 Japan Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 354 Japan Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 355 Japan Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 356 Japan Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 357 Japan Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 358 Japan Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 359 Japan Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 360 Japan Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 361 Japan Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 362 Japan Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 363 Japan Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 364 Japan Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 365 India Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 366 India Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 367 India Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 368 India Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 369 India Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 370 India Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 371 India Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 372 India Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 373 India Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 374 India Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 375 India Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 376 India Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 377 South Korea Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 378 South Korea Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 379 South Korea Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 380 South Korea Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 381 South Korea Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 382 South Korea Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 383 South Korea Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 384 South Korea Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 385 South Korea Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 386 South Korea Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 387 South Korea Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 388 South Korea Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 389 Singapore Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 390 Singapore Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 391 Singapore Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 392 Singapore Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 393 Singapore Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 394 Singapore Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 395 Singapore Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 396 Singapore Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 397 Singapore Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 398 Singapore Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 399 Singapore Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 400 Singapore Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 401 Malaysia Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 402 Malaysia Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 403 Malaysia Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 404 Malaysia Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 405 Malaysia Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 406 Malaysia Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 407 Malaysia Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 408 Malaysia Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 409 Malaysia Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 410 Malaysia Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 411 Malaysia Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 412 Malaysia Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 413 Rest of Asia Pacific Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 414 Rest of Asia Pacific Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 415 Rest of Asia Pacific Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 416 Rest of Asia Pacific Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 417 Rest of Asia Pacific Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 418 Rest of Asia Pacific Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 419 Rest of Asia Pacific Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 420 Rest of Asia Pacific Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 421 Rest of Asia Pacific Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 422 Rest of Asia Pacific Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 423 Rest of Asia Pacific Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 424 Rest of Asia Pacific Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 425 LAMEA Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 426 LAMEA Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 427 LAMEA Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 428 LAMEA Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 429 LAMEA Drugs Market by Country, 2018 - 2021, USD Thousands
TABLE 430 LAMEA Drugs Market by Country, 2022 - 2028, USD Thousands
TABLE 431 LAMEA Diagnostic Tests Market by Country, 2018 - 2021, USD Thousands
TABLE 432 LAMEA Diagnostic Tests Market by Country, 2022 - 2028, USD Thousands
TABLE 433 LAMEA Probiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 434 LAMEA Probiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 435 LAMEA Prebiotics Market by Country, 2018 - 2021, USD Thousands
TABLE 436 LAMEA Prebiotics Market by Country, 2022 - 2028, USD Thousands
TABLE 437 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
TABLE 438 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
TABLE 439 LAMEA Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 440 LAMEA Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 441 LAMEA Infectious Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 442 LAMEA Infectious Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 443 LAMEA Endocrine & Metabolic Disorders Market by Country, 2018 - 2021, USD Thousands
TABLE 444 LAMEA Endocrine & Metabolic Disorders Market by Country, 2022 - 2028, USD Thousands
TABLE 445 LAMEA Gastrointestinal Diseases Market by Country, 2018 - 2021, USD Thousands
TABLE 446 LAMEA Gastrointestinal Diseases Market by Country, 2022 - 2028, USD Thousands
TABLE 447 LAMEA Cancer Market by Country, 2018 - 2021, USD Thousands
TABLE 448 LAMEA Cancer Market by Country, 2022 - 2028, USD Thousands
TABLE 449 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
TABLE 450 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
TABLE 451 LAMEA Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 452 LAMEA Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 453 LAMEA Genomics Market by Country, 2018 - 2021, USD Thousands
TABLE 454 LAMEA Genomics Market by Country, 2022 - 2028, USD Thousands
TABLE 455 LAMEA Proteomics Market by Country, 2018 - 2021, USD Thousands
TABLE 456 LAMEA Proteomics Market by Country, 2022 - 2028, USD Thousands
TABLE 457 LAMEA Metabolomics Market by Country, 2018 - 2021, USD Thousands
TABLE 458 LAMEA Metabolomics Market by Country, 2022 - 2028, USD Thousands
TABLE 459 LAMEA Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 460 LAMEA Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 461 LAMEA Therapeutics Market by Country, 2018 - 2021, USD Thousands
TABLE 462 LAMEA Therapeutics Market by Country, 2022 - 2028, USD Thousands
TABLE 463 LAMEA Diagnostics Market by Country, 2018 - 2021, USD Thousands
TABLE 464 LAMEA Diagnostics Market by Country, 2022 - 2028, USD Thousands
TABLE 465 LAMEA Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 466 LAMEA Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 467 LAMEA Microbiome Consortia Transplantation (FMT) Market by Country, 2018 - 2021, USD Thousands
TABLE 468 LAMEA Microbiome Consortia Transplantation (FMT) Market by Country, 2022 - 2028, USD Thousands
TABLE 469 LAMEA Peptide Market by Country, 2018 - 2021, USD Thousands
TABLE 470 LAMEA Peptide Market by Country, 2022 - 2028, USD Thousands
TABLE 471 LAMEA Live Biotherapeutic Product Market by Country, 2018 - 2021, USD Thousands
TABLE 472 LAMEA Live Biotherapeutic Product Market by Country, 2022 - 2028, USD Thousands
TABLE 473 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
TABLE 474 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
TABLE 475 LAMEA Human Microbiome Market by Country, 2018 - 2021, USD Thousands
TABLE 476 LAMEA Human Microbiome Market by Country, 2022 - 2028, USD Thousands
TABLE 477 Brazil Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 478 Brazil Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 479 Brazil Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 480 Brazil Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 481 Brazil Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 482 Brazil Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 483 Brazil Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 484 Brazil Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 485 Brazil Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 486 Brazil Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 487 Brazil Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 488 Brazil Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 489 Argentina Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 490 Argentina Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 491 Argentina Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 492 Argentina Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 493 Argentina Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 494 Argentina Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 495 Argentina Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 496 Argentina Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 497 Argentina Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 498 Argentina Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 499 Argentina Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 500 Argentina Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 501 UAE Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 502 UAE Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 503 UAE Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 504 UAE Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 505 UAE Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 506 UAE Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 507 UAE Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 508 UAE Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 509 UAE Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 510 UAE Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 511 UAE Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 512 UAE Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 513 Saudi Arabia Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 514 Saudi Arabia Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 515 Saudi Arabia Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 516 Saudi Arabia Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 517 Saudi Arabia Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 518 Saudi Arabia Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 519 Saudi Arabia Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 520 Saudi Arabia Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 521 Saudi Arabia Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 522 Saudi Arabia Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 523 Saudi Arabia Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 524 Saudi Arabia Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 525 South Africa Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 526 South Africa Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 527 South Africa Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 528 South Africa Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 529 South Africa Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 530 South Africa Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 531 South Africa Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 532 South Africa Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 533 South Africa Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 534 South Africa Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 535 South Africa Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 536 South Africa Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 537 Nigeria Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 538 Nigeria Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 539 Nigeria Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 540 Nigeria Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 541 Nigeria Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 542 Nigeria Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 543 Nigeria Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 544 Nigeria Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 545 Nigeria Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 546 Nigeria Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 547 Nigeria Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 548 Nigeria Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 549 Rest of LAMEA Human Microbiome Market, 2018 - 2021, USD Thousands
TABLE 550 Rest of LAMEA Human Microbiome Market, 2022 - 2028, USD Thousands
TABLE 551 Rest of LAMEA Human Microbiome Market by Product, 2018 - 2021, USD Thousands
TABLE 552 Rest of LAMEA Human Microbiome Market by Product, 2022 - 2028, USD Thousands
TABLE 553 Rest of LAMEA Human Microbiome Market by Disease Type, 2018 - 2021, USD Thousands
TABLE 554 Rest of LAMEA Human Microbiome Market by Disease Type, 2022 - 2028, USD Thousands
TABLE 555 Rest of LAMEA Human Microbiome Market by Technology, 2018 - 2021, USD Thousands
TABLE 556 Rest of LAMEA Human Microbiome Market by Technology, 2022 - 2028, USD Thousands
TABLE 557 Rest of LAMEA Human Microbiome Market by Application, 2018 - 2021, USD Thousands
TABLE 558 Rest of LAMEA Human Microbiome Market by Application, 2022 - 2028, USD Thousands
TABLE 559 Rest of LAMEA Human Microbiome Market by Type, 2018 - 2021, USD Thousands
TABLE 560 Rest of LAMEA Human Microbiome Market by Type, 2022 - 2028, USD Thousands
TABLE 561 key information – Ferring Holdings SA
TABLE 562 Key information – Enterome
TABLE 563 KEY INFORMATION – Seres Therapeutics, Inc.
TABLE 564 Key Information – 4D pharma plc
TABLE 565 key Information – OptiBiotix Health Plc
TABLE 566 Key Information – Synlogic, Inc.
TABLE 567 Key Information – Second Genome, Inc.
TABLE 568 Key Information – Vedanta Biosciences, Inc.
TABLE 569 key information – Finch Therapeutics Group, Inc.

List of Figures
FIG 1 Methodology for the research
FIG 2 Global Human Microbiome Market Share, By Product, 2021
FIG 3 Global Human Microbiome Market Share, By Product, 2028
FIG 4 Global Human Microbiome Market Size, By Product, 2018 - 2028, USD Thousands
FIG 5 Global Human Microbiome Market Share, By Disease Type, 2021
FIG 6 Global Human Microbiome Market Share, By Disease Type, 2028
FIG 7 Global Human Microbiome Market Size, By Disease Type, 2018 - 2028, USD Thousands
FIG 8 Global Human Microbiome Market Share, By Technology, 2021
FIG 9 Global Human Microbiome Market Share, By Technology, 2028
FIG 10 Global Human Microbiome Market Size, By Technology, 2018 - 2028, USD Thousands
FIG 11 Global Human Microbiome Market Share, By Application, 2021
FIG 12 Global Human Microbiome Market Share, By Application, 2021
FIG 13 Global Human Microbiome Market Size, By Application, 2018 - 2028, USD Thousands
FIG 14 Global Human Microbiome Market Share, By Type, 2021
FIG 15 Global Human Microbiome Market Share, By Type, 2028
FIG 16 Global Human Microbiome Market Size, By Type, 2018 - 2028, USD Thousands
FIG 17 Global Human Microbiome Market Share, By Region, 2021
FIG 18 Global Human Microbiome Market Share, By Region, 2021
FIG 19 Global Human Microbiome Market Size, By Region, 2018 - 2028, USD Thousands